✦ LIBER ✦
Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma : A randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA)
✍ Scribed by Vincent Ribrag; Christian Gisselbrecht; Corinne Haioun; Gilles Salles; Jean-Baptiste Golfier; Marjan Ertault; Christophe Ferme; Josette Briere; Pauline Brice; Nicolas Mounier
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 170 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.